Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with India-based Spinco Biotech to further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback